TRPA1 and susceptibility to pneumonia measurement: Consequently, TRPA1 has emerged as a key target for treating respiratory tract inflammation, particularly lung inflammation, making the search for novel TRPA1 channel modulators essential for the development of safe and effective drugs for pneumonia [6].